A Phase 1b, 4-Period Crossover, Placebo-Controlled, Randomized, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-925 in Sleep-Deprived Healthy Adults Utilizing Modafinil as an Active Comparator
Phase of Trial: Phase I
Latest Information Update: 27 Nov 2019
Price : $35 *
At a glance
- Drugs TAK-925 (Primary) ; Modafinil
- Indications Narcolepsy
- Focus Therapeutic Use
- Sponsors Takeda
- 25 Sep 2019 According to a Takeda Pharma media release, the data from this study were presented at the World Sleep 2019 Biennial Congress in Vancouver, Canada.
- 25 Sep 2019 Results published in the Takeda Pharma Media Release
- 12 Nov 2018 Status changed from active, no longer recruiting to completed.